Aurinia Pharmaceuticals Inc. (AUPH)

NASDAQ: AUPH · IEX Real-Time Price · USD

5.43

-0.06 (-1.09%)

At close: Jul 2, 2024, 4:00 PM

5.48

+0.05 (0.92%)

After-hours: Jul 2, 2024, 6:18 PM EDT

Aurinia Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2012
Net Income	-78.02	-108.18	-180.97	-102.68	-88.39	Upgrade
Depreciation & Amortization	11.65	2.71	2.76	1.37	1.17	Upgrade
Share-Based Compensation	45.31	32.3	31.24	17.45	7.41	Upgrade
Other Operating Activities	-12.4	-6.36	-10.73	14	16.22	Upgrade
Operating Cash Flow	-33.46	-79.53	-157.69	-69.86	-63.59	Upgrade
Capital Expenditures	-0.72	-0.29	-1.5	-7.34	-0.1	Upgrade
Change in Investments	5.88	-59.68	-84.53	-150.84	7.88	Upgrade
Other Investing Activities	-11.86	-0.66	-17.84	-	-	Upgrade
Investing Cash Flow	-6.71	-60.63	-103.87	-158.19	7.78	Upgrade
Share Issuance / Repurchase	4.9	2.43	221.11	194.38	243.85	Upgrade
Debt Issued / Paid	-10.03	0	0	0	0	Upgrade
Financing Cash Flow	-5.13	2.43	221.11	194.38	243.85	Upgrade
Net Cash Flow	-45.3	-137.73	-40.45	-33.67	188.05	Upgrade
Free Cash Flow	-34.18	-79.82	-159.19	-77.2	-63.69	Upgrade
Free Cash Flow Margin	-19.47%	-59.55%	-349.07%	-154.04%	-20027.04%	Upgrade
Free Cash Flow Per Share	-0.24	-0.56	-1.23	-0.65	-0.69	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).